# Gamgee

> Founded by Paul Conyngham following his work on Rosie’s personalised mRNA cancer vaccine, Gamgee is developing investigational, tumour-specific cancer treatment protocols for dogs through licensed veterinary professionals.

This site provides general information, not veterinary advice. Rosie’s story describes one dog’s experience and should not be treated as proof of efficacy or a promise of outcomes. Availability, selection, and regulatory status vary by country.

## Core pages

- [Gamgee](https://www.gamgee.io/): Overview of Gamgee’s personalised mRNA cancer treatment program for dogs, the application-to-treatment process, and current trial access.
- [Rosie’s story](https://www.gamgee.io/story/): Paul Conyngham’s account of Rosie’s mast cell cancer, the AI-assisted personalised mRNA vaccine process, the treatment timeline, collaborators, and the limits of a single case.
- [Our mission](https://www.gamgee.io/mission/): Gamgee’s approach to AI-first genomics and N-of-1 medicine, beginning with personalised mRNA cancer vaccines for dogs.
- [For veterinarians](https://www.gamgee.io/vet/): Program information for veterinary professionals, including referral pathways, sample requirements, the process timeline, and the technical approach.

## Optional

- [News, research, and media](https://www.gamgee.io/media/): Reporting, scientific commentary, interviews, and other coverage of Rosie’s case and Gamgee.